Produse farmaceutice
Information about customer
Title
CENTRUL PENTRU ACHIZITII PUBLICE CENTRALIZATE IN SANATATE
IDNO
1016601000212
Address
MOLDOVA,
locality,
MD-2009, Republica Moldova, Chişinău str. Cosmescu 3,
MD-2009
The contact person
Macari Doina,
doina.macari@capcs.md
Purchase data
ID
ocds-b3wdp1-MD-1662642363960
Title
Produse farmaceutice
Note
CPV Code
33600000-6 - Produse farmaceutice
Rationale
List of funding sources
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1662642364697
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1662642364812
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1667811777401
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1668161367903
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1667811777507
IBAN
None
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1668161368018
IBAN
None
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670333943657
IBAN
None
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670333944008
IBAN
None
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670333944185
IBAN
None
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670333943496
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670333944377
IBAN
None
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670333943829
IBAN
None
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670478963337
IBAN
None
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670478963087
IBAN
None
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670478963582
IBAN
None
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670478963856
IBAN
None
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670478962643
IBAN
MD68TRPCCC518430A01859AA
Funding source cost
6574069.08 MDL
Funding source period
From 1 Jan 2023 to 1 Jan 2024
Funding source ID
ocds-b3wdp1-MD-1662642363960-FS-1670478962804
IBAN
None
Status Planning
Start the procedure:
1 Jan 2023
1 Jan 2024
Date of publication: 8 Sep 2022 16:06
Date of last modifications: 20 Dec 2022 18:34